Novartis AG Selling, General and Administrative Expense
Novartis AG (NVS) reported Selling, General and Administrative Expense of $13.25 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SellingGeneralAndAdministrativeExpense · last filed 2026-02-04
- Novartis AG selling general and administrative expense for the quarter ending 2025-06-30 was $3.44B, a 11.36% increase year-over-year.
- Novartis AG selling general and administrative expense for the quarter ending 2024-06-30 was $3.09B, a 0.00% change year-over-year.
- Novartis AG selling general and administrative expense for the quarter ending 2023-06-30 was $3.09B, a 13.68% decline year-over-year.
- Novartis AG selling general and administrative expense for the quarter ending 2022-06-30 was $3.58B, a 4.61% decline year-over-year.
| Period end | Selling General And Administrative Expense 3 month | Selling General And Administrative Expense 3 month as first filed | Selling General And Administrative Expense 6 month | Selling General And Administrative Expense 6 month as first filed | Selling General And Administrative Expense 12 month | Selling General And Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $13.25B 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $3.44B 6-K · filed 2025-07-17 | $6.50B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $12.57B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $3.09B 6-K · filed 2025-07-17 | $5.93B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $12.52B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $3.09B 6-K · filed 2024-07-18 | $3.69B 6-K · filed 2023-07-18 | $5.98B 6-K · filed 2024-07-18 | $7.13B 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $12.19B 20-F · filed 2025-01-31 | $14.25B 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $3.58B 6-K · filed 2023-07-18 | $7.09B 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $12.83B 20-F · filed 2024-01-31 | $14.89B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $3.75B 6-K · filed 2022-07-19 | $7.28B 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $14.20B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $3.37B 6-K · filed 2021-07-21 | $6.85B 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $14.37B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $3.58B 6-K · filed 2020-07-21 | $6.92B 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $13.72B 20-F · filed 2021-01-26 | $16.47B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | $3.50B 6-K · filed 2019-07-18 | $4.19B 6-K · filed 2018-07-18 | $6.78B 6-K · filed 2019-07-18 | $8.12B 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $12.46B 20-F · filed 2020-01-29 | $15.00B 20-F · filed 2019-01-30 | ||||
| 2017-06-30 | $3.81B 6-K · filed 2018-07-18 | $7.28B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $14.19B 20-F · filed 2019-01-30 |